PURE Bioscience, Inc.
PURE
$0.08
$0.00-1.21%
OTC PK
| 01/31/2026 | 10/31/2025 | 07/31/2025 | 04/30/2025 | 01/31/2025 | |
|---|---|---|---|---|---|
| Net Income | -2.16M | -2.17M | -2.40M | -2.82M | -3.10M |
| Total Depreciation and Amortization | 3.00K | 3.00K | 2.00K | 40.00K | 75.00K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 155.00K | 124.00K | 147.00K | 155.00K | 214.00K |
| Change in Net Operating Assets | 179.00K | 285.00K | 235.00K | 476.00K | 556.00K |
| Cash from Operations | -1.82M | -1.76M | -2.02M | -2.15M | -2.26M |
| Capital Expenditure | -- | -- | -- | -- | -- |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -- | -- | -- | -- | -- |
| Cash from Investing | -- | -- | -- | -- | -- |
| Total Debt Issued | 1.82M | 1.85M | 2.00M | 2.25M | 1.90M |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | -- | -- | -- | -- | -- |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | -- | -- | -- | -- | -- |
| Cash from Financing | 1.82M | 1.85M | 2.00M | 2.25M | 1.90M |
| Foreign Exchange rate Adjustments | -- | -- | -- | -- | -- |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -4.00K | 88.00K | -15.00K | 98.00K | -355.00K |